Name | N-hydroxy-2-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)pyrimidine-5-carboxamide |
---|---|
Synonyms |
N-Hydroxy-2-[4-(2-naphthylsulfonyl)-1-piperazinyl]-5-pyrimidinecarboxamide
5-Pyrimidinecarboxamide, N-hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]- unii-5wd7kk1iiq R306465 JNJ-16241199 |
Description | JNJ-16241199 is an orally active, selective hydroxamate-based histone deacetylase (HDAC) inhibitor, with the IC50 of 3.3 nM and 23 nM for HDAC1 and HDAC8, respectively. JNJ-16241199 induces histone 3 acetylation and strongly increases the expression of p21waf1, cip1 in A2780 ovarian carcinoma cells. JNJ-16241199 induces cell apoptosis and shows anticancer activity in a broad spectrum of human malignancies. JNJ-16241199 can be used for cancer study[1]. |
---|---|
Related Catalog | |
Target |
HDAC1:3.3 nM (IC50) HDAC8:23 nM (IC50) |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C19H19N5O4S |
Molecular Weight | 413.45 |
Exact Mass | 413.115784 |
PSA | 124.11000 |
LogP | 2.06 |
Index of Refraction | 1.689 |
HS Code | 2933990090 |
---|
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |